Health
Health
Climate Change May Raise Dengue Cases in Kerala by 2040
A study finds climate change and shifting monsoon patterns could increase dengue risk in Kerala, with cases potentially rising by 20% by 2040.
Health
Pennsylvania Reports Fourth Measles-Associated Death in 2026
Pennsylvania officials report a fourth measles-associated death as the state records over 600 cases this year amid a wider US measles surge.
Health
Why You Feel Guilty Taking a Sick Day From Work
Feeling guilty about taking a sick day may be linked to workplace culture, work identity and fear of being judged, experts say.
Health
India’s Organ Transplant Gender Gap: Women Donate, Men Receive
NOTTO data shows women made up 63.8% of living organ donors while men accounted for 69.8% of transplant recipients in India from 2019 to 2023.
Health
IMA Haryana Withdraws Ayushman Bharat Service Suspension
IMA Haryana has withdrawn its planned indefinite suspension of Ayushman Bharat services after CM Nayab Singh Saini assured action on hospital concerns.
Health
CDSCO Alerts Against Unauthorised Pakistani Whitening Creams
CDSCO has warned against unauthorised Pakistani whitening creams sold in India, citing excessive heavy metals and potential health risks.
Health
Dual Nerve Block May Ease Treatment-Resistant Anxiety
A clinical trial found that a dual stellate ganglion block may reduce anxiety symptoms in patients who do not respond to standard treatments.
Health
BRICS Healthy Lifestyle Mission: Why Prevention Matters
The BRICS Healthy Lifestyle Mission highlights prevention, nutrition and healthier communities as India faces changing health risks and lifestyle-related challenges.
Health
Dr Reddy’s Launches Nivorz in India’s Biosimilar Market
Dr Reddy’s enters India’s biosimilar immuno-oncology market with Nivorz, a biosimilar of nivolumab, developed and manufactured at its Hyderabad facility.
Health
Aurobindo Pharma Gets U.S. FDA Nod for Asthma Inhaler
Aurobindo Pharma has received final U.S. FDA approval to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths. The generic asthma inhaler is equivalent to QVAR and is intended for the maintenance treatment of asthma. The product will be manufactured at the company’s subsidiary Aurolife Pharma’s facility in Raleigh, North Carolina, and is expected